Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efavirenz”

296 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 296 results

Large-scale testing (Phase 3)Study completedNCT00323544
What this trial is testing

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 220
Testing effectiveness (Phase 2)Study completedNCT02412436
What this trial is testing

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Who this might be right for
HIV-1 InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 62
Post-approval studies (Phase 4)Ended earlyNCT00765154
What this trial is testing

NNRTI/PI Toxicity Switch to Darunavir Study

Who this might be right for
HIV
St Stephens Aids Trust 12
Post-approval studies (Phase 4)Study completedNCT00549198
What this trial is testing

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
GlaxoSmithKline 392
Large-scale testing (Phase 3)Study completedNCT00050895
What this trial is testing

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 775
Early research (Phase 1)Study completedNCT06698016
What this trial is testing

The Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014)

Who this might be right for
Healthy
Merck Sharp & Dohme LLC 16
Post-approval studies (Phase 4)Study completedNCT00116116
What this trial is testing

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Who this might be right for
HIV InfectionsAIDS
Bristol-Myers Squibb 70
Not applicableUnknownNCT01704144
What this trial is testing

Rifampin and Efavirenz Interactions in Older Children

Who this might be right for
HIVTuberculosis
The Miriam Hospital 160
Not applicableStudy completedNCT00100568
What this trial is testing

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 44
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Early research (Phase 1)UnknownNCT02421289
What this trial is testing

Influence of Cytochrome P2B6 on Efavirenz Dose in HIV-infected Thai Patients

Who this might be right for
Cytochrome P-450 CYP2B6EfavirenzHIV
Mahidol University 190
Post-approval studies (Phase 4)Study completedNCT00862823
What this trial is testing

The Bioequivalence of Atripla in an Oral Liquid Formulation Compared With the Tablet Formulation in Healthy Volunteers

Who this might be right for
Healthy
University of Alabama at Birmingham 14
Large-scale testing (Phase 3)UnknownNCT04429152
What this trial is testing

ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance

Who this might be right for
HIV-1-infection
Professor Francois Venter 25
Post-approval studies (Phase 4)Study completedNCT00771498
What this trial is testing

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Who this might be right for
HIV InfectionTuberculosis
Oswaldo Cruz Foundation 30
Testing effectiveness (Phase 2)Study completedNCT03282799
What this trial is testing

Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women

Who this might be right for
HIV/AIDSContraception
Catherine Anne Chappell 72
Testing effectiveness (Phase 2)Study completedNCT01789879
What this trial is testing

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy

Who this might be right for
HIVContraception
University of Nebraska 60
Large-scale testing (Phase 3)Study completedNCT01451333
What this trial is testing

The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1

Who this might be right for
HIV Infection
Kirby Institute 32
Testing effectiveness (Phase 2)Study completedNCT00100048
What this trial is testing

Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC 206
Testing effectiveness (Phase 2)Study completedNCT00001086
What this trial is testing

Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT00053638
What this trial is testing

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

Who this might be right for
HIV Infection
GlaxoSmithKline 345
Load More Results